{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:43:29Z","timestamp":1781678609795,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH's National Center for Advancing Translational Sciences"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.addbeh.2019.01.023","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:41:05Z","timestamp":1547638865000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialties"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-7814","authenticated-orcid":false,"given":"Lewei (Allison)","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.addbeh.2019.01.023_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1370\/afm.2099","article-title":"Barriers rural physicians face prescribing buprenorphine for opioid use disorder","volume":"15","author":"Andrilla","year":"2017","journal-title":"Annals of Family Medicine"},{"issue":"5","key":"10.1016\/j.addbeh.2019.01.023_bb0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/ADM.0000000000000247","article-title":"The availability of ancillary counseling in the practices of physicians prescribing buprenorphine","volume":"10","author":"Barry","year":"2016","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.addbeh.2019.01.023_bb0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: Development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"8","key":"10.1016\/j.addbeh.2019.01.023_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","article-title":"The role of behavioral interventions in buprenorphine maintenance treatment: A review","volume":"174","author":"Carroll","year":"2017","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjmed.2012.07.005","article-title":"A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine","volume":"126","author":"Fiellin","year":"2013","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2015.1088496","article-title":"Optimizing psychosocial support during office-based buprenorphine treatment in primary care: patients' experiences and preferences","volume":"37","author":"Fox","year":"2016","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of DSM-5 drug use disorder: Results from the national epidemiologic survey on alcohol and related conditions\u2013III","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.023_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.10.005","article-title":"Buprenorphine prescribing practice trends and attitudes among New York providers","volume":"74","author":"Kermack","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13011-015-0039-9","article-title":"Physicians discuss the risks of smoking with their patients, but seldom offer practical cessation support","volume":"10","author":"Keto","year":"2015","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2013.08.009","article-title":"A randomized trial of web-based videoconferencing for substance abuse counseling","volume":"46","author":"King","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/ADM.0000000000000360","article-title":"Physicians' decision-making when implementing buprenorphine with new patients: Conjoint analyses of data from a cohort of current prescribers","volume":"12","author":"Knudsen","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.addbeh.2019.01.023_bb0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0447.2012.01887.x","article-title":"Primary care physicians' and psychiatrists' approaches to treating mild depression","volume":"126","author":"Lawrence","year":"2012","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2018.01.015","article-title":"Perceptions and practices addressing diversion among US buprenorphine prescribers","volume":"186","author":"Lin","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.addbeh.2019.01.023_bb0075","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/add.12266","article-title":"Comparison of behavioral treatment conditions in buprenorphine maintenance","volume":"108","author":"Ling","year":"2013","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1747-597X-4-13","article-title":"A national physician survey on prescribing syringes as an HIV prevention measure","volume":"4","author":"Macalino","year":"2009","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0085","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsat.2015.05.005","article-title":"Buprenorphine treatment and 12-step meeting attendance: Conflicts, compatibilities, and patient outcomes","volume":"57","author":"Monico","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.addbeh.2019.01.023_bb0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2017.0001","article-title":"Opioid agonist treatment for patients with dependence on prescription opioids","volume":"317","author":"Nielsen","year":"2017","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsat.2018.11.003","article-title":"Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system","volume":"97","author":"Rawson","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0115","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0120","series-title":"Medications to treat opioid use disorder. Treatment improvement protocol (TIP) series 63, full document","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"issue":"1","key":"10.1016\/j.addbeh.2019.01.023_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08897077.2015.1132292","article-title":"Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment","volume":"37","author":"Suzuki","year":"2016","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.addbeh.2019.01.023_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2012.07.011","article-title":"Brief versus extended counseling along with buprenorphine\/naloxone for HIV-infected opioid dependent patients","volume":"43","author":"Tetrault","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2019.01.023_bb0135","author":"US Department of Agriculture, E.R.S"},{"issue":"9","key":"10.1016\/j.addbeh.2019.01.023_bb0140","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers","volume":"23","author":"Walley","year":"2008","journal-title":"Journal of General Internal Medicine"},{"issue":"10","key":"10.1016\/j.addbeh.2019.01.023_bb0145","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jamainternmed.2017.3947","article-title":"Collaborative care for opioid and alcohol use disorders in primary care: The SUMMIT randomized clinical trial","volume":"177","author":"Watkins","year":"2017","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"10.1016\/j.addbeh.2019.01.023_bb0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1176\/ajp.2007.164.2.276","article-title":"Psychiatric treatment in primary care patients with anxiety disorders: A comparison of care received from primary care providers and psychiatrists","volume":"164","author":"Weisberg","year":"2007","journal-title":"The American Journal of Psychiatry"},{"issue":"12","key":"10.1016\/j.addbeh.2019.01.023_bb0155","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460318311584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460318311584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:36:04Z","timestamp":1759689364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460318311584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":31,"alternative-id":["S0306460318311584"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2019.01.023","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceived need and availability of psychosocial interventions across buprenorphine prescriber specialties","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2019.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}